Pediatrics Flashcards
which 2 vitals are elevated in children compared to adults
HR and RR
limitations of off-label drug usage in children
insurance denial
liability for AEs
limited experience
limited dosage forms
which factors impact drug absorption in peds
higher gastric ph
slower gastric emptying
reduced frequency and amplitude of contractions
how is IM bioavailability in children compared to adults? why
increased bioavailability due to capillary density
what impacts Vd in peds? how?
higher total body water and ECF
inc Vd of hydrophilic and dec Vd of lipophilic drugs
cause and effect of protein binding differences in peds
dec concentration of circulating protein
inc free fraction of drugs
cause and effect of elimination differences in peds
dec renal BF, GFR, and tubular secretion
slower CL, longer t1/2
less frequent dosing needed
what is the primary reason for noncompliance in children
palatability
how is dosing done for peds?
mg/kg/dose or mg/kg/day
neonatal age from conception, how far along in pregnancy
gestational age
neonatal chronological age, time since birthday
post-natal age
neonatal age combination of GA + PNA
post-menstrual age
age for birth to 30 days
neonate
age for 30 days to 1 year old
infant
age for 1 to 12 years old
child
age for 12 to 18 years old
adolescent
1 kg =
2.2 lbs
1 inch =
2.54 cm
BSA equation =
sqrt [(height cm x weight kg) / 3600]
the administration section of lexi has recommendations for
food & drink allowable for mixing
adverse reactions of lexi may be
specific to age, provide % incidence
which section of lexi can help in determining parenteral to enteral conversions
PK/MOA
which section of lexi can help determine what is commercially available
dosage forms
how to calculate % severity of dehydration =
[ (preillness weight - illness weight) / preillness weight ] x 100
weight in kg
fluid deficit (L) equation =
(% dehydration x preillness weight) / 100
% dehydration if mild
infants- 1-5%
children 1-3%
% dehydration if moderate
infants 6-9%
children 4-6%
% dehydration if severe
infants >10% (>15 if shock)
children >6% (>9 if shock)
S/S of mild dehydration
slight dry mucosa, decreased UOP, inc pulse
s/s of moderate dehydration
tachycardia, norm/low BP, little/no UOP, dry mucosa, sunken face, cool pale, decreased tears, thirsty
s/s of severe dehydration
rapid & weak pulse, very low BP, oliguria, parched mucosa, very sunken and cool, no tears, lethargic, unable to drink
therapy for mild dehydration
ORT 50 ml/kg over 4 hours
add 10ml/kg for each loose stool/vomit episode
therapy for moderate dehydration
100 ml/kg over 4 hours
add 10ml/kg for each loose stool/vomit episode
therapy for severe dehydration
iv fluids
phase 1 iv fluid dose for dehydration
10-20 ml/kg/dose of NS or LR over 30-60 min up to 3 times
phase II of IV fluids for severe dehydration? max rate?
maintenance
max 100ml/hr and no more than 1.5-2x MIVF
what should be included in an iv fluid bag
NS- isotonic
D5W
K 20 mEq/L
when should you use caution with potassium in IV fluids
renal failure, neonates
what can be used in those >6 mos for gastroenteritis
ondansetron
dosage forms of zinc are expressed in salt, which is what % elemental
23%
how many weeks is a premature, term, and post term neonate
premature <37 weeks
term 38-41 weeks
post-term >42 weeks
what age is toddler, early, and older school
toddler- 1-4 yr
early- 5-7 yr
older 8-12 yr
weight gain for infants
20-30 grams per day
inadequate growth or inability to maintain growth in early childhood
failure to thrive
breastmilk calorie contents
20 kcal/oz
vit d requirements for breastfed infants
400IU/day starting first few days of life
fluoride recommendations for breastfed infants
0.5 mg/day when >6 months old
1-2 mg/kg/day of what may be supplemented in breastfed or pre term infants
iron
caution with what in a toddlers diet?
fruit juice
condition in infants that manifests as spitting up or regurgitation and resolves by 12-14 months
GER
condition in infants characterized by excessive regurgitation, food refusal, abdominal pain, etc.
GERD
risk factors for GERD in children
locus on chromosome 12, neurologic impairment, obesity, esophageal atresia, chronic lung disease, prematurity